Displaying drugs 6901 - 6925 of 8297 in total
Firategrast
Firategrast has been used in trials studying the treatment of Multiple Sclerosis.
Investigational
Matched Description: … Firategrast has been used in trials studying the treatment of Multiple Sclerosis. …
Tiplimotide
Tiplimotide has been used in trials studying the treatment of Multiple Sclerosis.
Investigational
Matched Description: … Tiplimotide has been used in trials studying the treatment of Multiple Sclerosis. …
GW-493838
GW493838 has been used in trials studying the treatment of Neuropathic Pain.
Investigational
Matched Description: … GW493838 has been used in trials studying the treatment of Neuropathic Pain. …
Hydroxytyrosol
Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Description: … Hydroxytyrosol has been used in trials studying the prevention of Breast Cancer. …
E-6005
E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational
Matched Description: … E6005 has been used in trials studying the treatment of Atopic Dermatitis. …
SCH-486757
Sch 486757 has been used in trials studying the treatment of Cough.
Investigational
Matched Description: … Sch 486757 has been used in trials studying the treatment of Cough. …
p-Quaterphenyl
p-Quaterphenyl has been used in trials studying the treatment of Malaria.
Investigational
Matched Description: … p-Quaterphenyl has been used in trials studying the treatment of Malaria. …
Laniquidar
Laniquidar has been used in trials studying the treatment of Breast Cancer.
Investigational
Matched Description: … Laniquidar has been used in trials studying the treatment of Breast Cancer. …
PF-04217903
PF-04217903 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
Clazakizumab
Clazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
Matched Description: … Clazakizumab has been used in trials studying the treatment of Rheumatoid Arthritis. …
Timonacic
Timonacic has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Timonacic has been used in trials studying the treatment of HIV Infections. …
Raluridine
Raluridine has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Raluridine has been used in trials studying the treatment of HIV Infections. …
Roniciclib
Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma.
Investigational
Matched Description: … Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma. …
Cibinetide
Cibinetide has been used in trials studying the basic science of Depression.
Investigational
Matched Description: … Cibinetide has been used in trials studying the basic science of Depression. …
Hypericin
Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma.
Investigational
Matched Description: … Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma. …
LY-2874455
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
Investigational
Matched Description: … LY2874455 has been used in trials studying the treatment of Advanced Cancer. …
Tucaresol
Tucaresol has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Tucaresol has been used in trials studying the treatment of HIV Infections. …
Biapenem
Biapenem has been used in trials studying the treatment of Bacterial Infections.
Investigational
Matched Description: … Biapenem has been used in trials studying the treatment of Bacterial Infections. …
Methanesulfonyl Fluoride
Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.
Investigational
Matched Description: … Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety. …
Nefiracetam
Nefiracetam has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Description: … Nefiracetam has been used in trials studying the treatment of Alzheimer's Disease. …
Ketodarolutamide
Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of darolutamide.
Experimental
Matched Description: … Ketodarolutamide, a nonsteroidal antiandrogen (NSAA), is the major active metabolite of [darolutamide …
GSBR-1290
GSBR-1290 is a small molecule agonist of the GLP-1 receptor.
Investigational
Matched Description: … GSBR-1290 is a small molecule agonist of the GLP-1 receptor. …
Ferric pyrophosphate
Ferric pyrophosphate is an iron replacement product. Free iron presents several side effects as it can catalyze free radical formation and lipid peroxidation as well as the presence of interactions of iron in plasma. The ferric ion is strongly complexed by pyrophosphate. It presents an increasing interest as this insoluble...
Experimental
Matched Description: … interactions of iron in plasma. ... side effects as it can catalyze free radical formation and lipid peroxidation as well as the presence of …
Putrescine
Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine. Putrescine is a solid. This compound belongs to the polyamines. These are compounds containing more than one amine group. Known drug targets of putrescine include putrescine-binding periplasmic protein, ornithine decarboxylase, and S-adenosylmethionine decarboxylase proenzyme.
Experimental
Matched Description: … Putrescine is a toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine ... Known drug targets of putrescine include putrescine-binding periplasmic protein, ornithine decarboxylase …
MK-0354
MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis and related disorders. It targets G protein-coupled receptor, or GPCR, that have the potential to regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of niacin.
Investigational
Matched Description: … MK-0354, is an orally administered drug candidate under development by Merck for the treatment of atherosclerosis ... regulate plasma lipid profiles, including HDL, or the good cholesterol, similar to the therapeutic action of …
Displaying drugs 6901 - 6925 of 8297 in total